| Year |
Citation |
Score |
| 2023 |
Sims JR, Zimmer JA, Evans CD, Lu M, Ardayfio P, Sparks J, Wessels AM, Shcherbinin S, Wang H, Monkul Nery ES, Collins EC, Solomon P, Salloway S, Apostolova LG, Hansson O, ... Skovronsky DM, et al. Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial. Jama. PMID 37459141 DOI: 10.1001/jama.2023.13239 |
0.614 |
|
| 2021 |
Dougan M, Azizad M, Mocherla B, Gottlieb RL, Chen P, Hebert C, Perry R, Boscia J, Heller B, Morris J, Crystal C, Igbinadolor A, Huhn G, Cardona J, Shawa I, ... Skovronsky DM, et al. A randomized, placebo-controlled clinical trial of bamlanivimab and etesevimab together in high-risk ambulatory patients with COVID-19 and validation of the prognostic value of persistently high viral load. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 34718468 DOI: 10.1093/cid/ciab912 |
0.535 |
|
| 2021 |
Dougan M, Nirula A, Azizad M, Mocherla B, Gottlieb RL, Chen P, Hebert C, Perry R, Boscia J, Heller B, Morris J, Crystal C, Igbinadolor A, Huhn G, Cardona J, ... Skovronsky DM, et al. Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19. The New England Journal of Medicine. PMID 34260849 DOI: 10.1056/NEJMoa2102685 |
0.548 |
|
| 2021 |
Cohen MS, Nirula A, Mulligan MJ, Novak RM, Marovich M, Yen C, Stemer A, Mayer SM, Wohl D, Brengle B, Montague BT, Frank I, McCulloh RJ, Fichtenbaum CJ, Lipson B, ... Skovronsky DM, et al. Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities: A Randomized Clinical Trial. Jama. PMID 34081073 DOI: 10.1001/jama.2021.8828 |
0.525 |
|
| 2021 |
Mintun MA, Lo AC, Duggan Evans C, Wessels AM, Ardayfio PA, Andersen SW, Shcherbinin S, Sparks J, Sims JR, Brys M, Apostolova LG, Salloway SP, Skovronsky DM. Donanemab in Early Alzheimer's Disease. The New England Journal of Medicine. PMID 33720637 DOI: 10.1056/NEJMoa2100708 |
0.656 |
|
| 2021 |
Gottlieb RL, Nirula A, Chen P, Boscia J, Heller B, Morris J, Huhn G, Cardona J, Mocherla B, Stosor V, Shawa I, Kumar P, Adams AC, Van Naarden J, Custer KL, ... Skovronsky DM, et al. Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial. Jama. PMID 33475701 DOI: 10.1001/jama.2021.0202 |
0.556 |
|
| 2020 |
Nirula A, Shen L, Skovronsky DM. Neutralizing Antibody LY-CoV555 for Outpatient Covid-19. Reply. The New England Journal of Medicine. 384. PMID 33378611 DOI: 10.1056/NEJMc2033787#sa2 |
0.518 |
|
| 2020 |
Chen P, Nirula A, Heller B, Gottlieb RL, Boscia J, Morris J, Huhn G, Cardona J, Mocherla B, Stosor V, Shawa I, Adams AC, Van Naarden J, Custer KL, Shen L, ... Skovronsky DM, et al. SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19. The New England Journal of Medicine. PMID 33113295 DOI: 10.1056/NEJMoa2029849 |
0.53 |
|
| 2016 |
Grundman M, Johnson KA, Lu M, Siderowf A, Dell'Agnello G, Arora AK, Skovronsky DM, Mintun MA, Pontecorvo MJ. Effect of Amyloid Imaging on the Diagnosis and Management of Patients with Cognitive Decline: Impact of Appropriate Use Criteria. Dementia and Geriatric Cognitive Disorders. 41: 80-92. PMID 26745445 DOI: 10.1159/000441139 |
0.685 |
|
| 2015 |
Joshi AD, Pontecorvo MJ, Skovronsky DM, Mintun MA, Lu M, Devous MD. A semi-automated method for quantification of florbetapir F 18 PET images. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 26338898 DOI: 10.2967/jnumed.114.153494 |
0.694 |
|
| 2015 |
Klunk WE, Koeppe RA, Price JC, Benzinger TL, Devous MD, Jagust WJ, Johnson KA, Mathis CA, Minhas D, Pontecorvo MJ, Rowe CC, Skovronsky DM, Mintun MA. The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: 1-15.e1-4. PMID 25443857 DOI: 10.1016/J.Jalz.2014.07.003 |
0.656 |
|
| 2015 |
Tateno A, Sakayori T, Kawashima Y, Higuchi M, Suhara T, Mizumura S, Mintun MA, Skovronsky DM, Honjo K, Ishihara K, Kumita S, Suzuki H, Okubo Y. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy. International Journal of Geriatric Psychiatry. 30: 505-13. PMID 25043833 DOI: 10.1002/gps.4173 |
0.686 |
|
| 2014 |
Siderowf A, Pontecorvo MJ, Shill HA, Mintun MA, Arora A, Joshi AD, Lu M, Adler CH, Galasko D, Liebsack C, Skovronsky DM, Sabbagh MN. PET imaging of amyloid with Florbetapir F 18 and PET imaging of dopamine degeneration with 18F-AV-133 (florbenazine) in patients with Alzheimer's disease and Lewy body disorders. Bmc Neurology. 14: 79. PMID 24716655 DOI: 10.1186/1471-2377-14-79 |
0.689 |
|
| 2014 |
Doraiswamy PM, Sperling RA, Johnson K, Reiman EM, Wong TZ, Sabbagh MN, Sadowsky CH, Fleisher AS, Carpenter A, Joshi AD, Lu M, Grundman M, Mintun MA, Skovronsky DM, Pontecorvo MJ, et al. Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study. Molecular Psychiatry. 19: 1044-51. PMID 24614494 DOI: 10.1038/Mp.2014.9 |
0.642 |
|
| 2014 |
Joshi AD, Pontecorvo MJ, Adler L, Stabin MG, Skovronsky DM, Carpenter AP, Mintun MA. Radiation dosimetry of florbetapir F 18. Ejnmmi Research. 4: 4. PMID 24401181 DOI: 10.1186/2191-219X-4-4 |
0.644 |
|
| 2014 |
Dugger BN, Clark CM, Serrano G, Mariner M, Bedell BJ, Coleman RE, Doraiswamy PM, Lu M, Fleisher AS, Reiman EM, Sabbagh MN, Sadowsky CH, Schneider JA, Zehntner SP, Carpenter AP, ... Skovronsky DM, et al. Neuropathologic heterogeneity does not impair florbetapir-positron emission tomography postmortem correlates. Journal of Neuropathology and Experimental Neurology. 73: 72-80. PMID 24335535 DOI: 10.1097/Nen.0000000000000028 |
0.704 |
|
| 2013 |
Rosenberg PB, Wong DF, Edell SL, Ross JS, Joshi AD, Brašić JR, Zhou Y, Raymont V, Kumar A, Ravert HT, Dannals RF, Pontecorvo MJ, Skovronsky DM, Lyketsos CG. Cognition and amyloid load in Alzheimer disease imaged with florbetapir F 18(AV-45) positron emission tomography. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 21: 272-8. PMID 23395194 DOI: 10.1016/J.Jagp.2012.11.016 |
0.707 |
|
| 2013 |
Johnson KA, Sperling RA, Gidicsin CM, Carmasin JS, Maye JE, Coleman RE, Reiman EM, Sabbagh MN, Sadowsky CH, Fleisher AS, Murali Doraiswamy P, Carpenter AP, Clark CM, Joshi AD, Lu M, ... Skovronsky DM, et al. Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: S72-83. PMID 23375563 DOI: 10.1016/J.Jalz.2012.10.007 |
0.704 |
|
| 2013 |
Grundman M, Pontecorvo MJ, Salloway SP, Doraiswamy PM, Fleisher AS, Sadowsky CH, Nair AK, Siderowf A, Lu M, Arora AK, Agbulos A, Flitter ML, Krautkramer MJ, Sarsour K, Skovronsky DM, et al. Potential impact of amyloid imaging on diagnosis and intended management in patients with progressive cognitive decline. Alzheimer Disease and Associated Disorders. 27: 4-15. PMID 23203162 DOI: 10.1097/Wad.0B013E318279D02A |
0.685 |
|
| 2013 |
Sperling RA, Johnson KA, Doraiswamy PM, Reiman EM, Fleisher AS, Sabbagh MN, Sadowsky CH, Carpenter A, Davis MD, Lu M, Flitter M, Joshi AD, Clark CM, Grundman M, Mintun MA, Skovronsky DM, et al. Amyloid deposition detected with florbetapir F 18 ((18)F-AV-45) is related to lower episodic memory performance in clinically normal older individuals. Neurobiology of Aging. 34: 822-31. PMID 22878163 DOI: 10.1016/j.neurobiolaging.2012.06.014 |
0.676 |
|
| 2013 |
Fleisher AS, Chen K, Liu X, Ayutyanont N, Roontiva A, Thiyyagura P, Protas H, Joshi AD, Sabbagh M, Sadowsky CH, Sperling RA, Clark CM, Mintun MA, Pontecorvo MJ, Coleman RE, ... Skovronsky DM, et al. Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease. Neurobiology of Aging. 34: 1-12. PMID 22633529 DOI: 10.1016/J.Neurobiolaging.2012.04.017 |
0.665 |
|
| 2013 |
Kolb H, Attardo G, Mintun M, Chien D, Elizarov A, Conti P, Miller C, Joshi A, Skovronsky D. DT-02-01: First case report: Image to autopsy correlation for tau imaging with [18F]-T808 (AV-680) Alzheimer's & Dementia. 9: P844-P845. DOI: 10.1016/J.Jalz.2013.08.008 |
0.629 |
|
| 2013 |
Witte M, Dugger B, Serrano G, Bedell BJ, Doraiswamy PM, Fleisher AS, Reiman E, Sabbagh MN, Sadowsky CH, Schneider JA, Carpenter AP, Joshi AD, Mintun MA, Pontecorvo MJ, Skovronsky DM, et al. Florbetapir PET Imaging Predicts Postmortem Amyloid Burden in Alzheimer's Disease Despite Presence of Other Neuropathologies The American Journal of Geriatric Psychiatry. 21: S138-S139. DOI: 10.1016/J.Jagp.2012.12.183 |
0.721 |
|
| 2013 |
Hochstetler H, Doraiswamy PM, Sperling RA, Johnson KA, Reiman E, Sabbagh MN, Sadowsky CH, Joshi AD, Lu M, Mintun MA, Pontecorvo MJ, Skovronsky DM. Relationship of Florbetapir F18 PET Amyloid Plaque Neuroimaging with Future Cognitive Decline over 36 Months The American Journal of Geriatric Psychiatry. 21: S136. DOI: 10.1016/j.jagp.2012.12.180 |
0.667 |
|
| 2012 |
Doraiswamy PM, Sperling RA, Coleman RE, Johnson KA, Reiman EM, Davis MD, Grundman M, Sabbagh MN, Sadowsky CH, Fleisher AS, Carpenter A, Clark CM, Joshi AD, Mintun MA, Skovronsky DM, et al. Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study. Neurology. 79: 1636-44. PMID 22786606 DOI: 10.1212/Wnl.0B013E3182661F74 |
0.701 |
|
| 2012 |
Clark CM, Pontecorvo MJ, Beach TG, Bedell BJ, Coleman RE, Doraiswamy PM, Fleisher AS, Reiman EM, Sabbagh MN, Sadowsky CH, Schneider JA, Arora A, Carpenter AP, Flitter ML, Joshi AD, ... Skovronsky DM, et al. Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study. The Lancet. Neurology. 11: 669-78. PMID 22749065 DOI: 10.1016/S1474-4422(12)70142-4 |
0.71 |
|
| 2012 |
Normandin MD, Petersen KF, Ding YS, Lin SF, Naik S, Fowles K, Skovronsky DM, Herold KC, McCarthy TJ, Calle RA, Carson RE, Treadway JL, Cline GW. In vivo imaging of endogenous pancreatic β-cell mass in healthy and type 1 diabetic subjects using 18F-fluoropropyl-dihydrotetrabenazine and PET. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 908-16. PMID 22573821 DOI: 10.2967/Jnumed.111.100545 |
0.662 |
|
| 2012 |
Choi SR, Schneider JA, Bennett DA, Beach TG, Bedell BJ, Zehntner SP, Krautkramer MJ, Kung HF, Skovronsky DM, Hefti F, Clark CM. Correlation of amyloid PET ligand florbetapir F 18 binding with Aβ aggregation and neuritic plaque deposition in postmortem brain tissue. Alzheimer Disease and Associated Disorders. 26: 8-16. PMID 22354138 DOI: 10.1097/Wad.0B013E31821300Bc |
0.735 |
|
| 2012 |
Joshi AD, Pontecorvo MJ, Clark CM, Carpenter AP, Jennings DL, Sadowsky CH, Adler LP, Kovnat KD, Seibyl JP, Arora A, Saha K, Burns JD, Lowrey MJ, Mintun MA, Skovronsky DM, et al. Performance characteristics of amyloid PET with florbetapir F 18 in patients with alzheimer's disease and cognitively normal subjects. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 378-84. PMID 22331215 DOI: 10.2967/Jnumed.111.090340 |
0.708 |
|
| 2012 |
Villemagne VL, Okamura N, Pejoska S, Drago J, Mulligan RS, Chételat G, O'Keefe G, Jones G, Kung HF, Pontecorvo M, Masters CL, Skovronsky DM, Rowe CC. Differential diagnosis in Alzheimer's disease and dementia with Lewy bodies via VMAT2 and amyloid imaging. Neuro-Degenerative Diseases. 10: 161-5. PMID 22261520 DOI: 10.1159/000334535 |
0.73 |
|
| 2012 |
Skovronsky D, Beach T, Bedell B, Coleman E, Reiman E, Schneider J, Joshi A, Mintun M, Pontecorvo M, Clark C. O1-04-03: Comparison of florbetapir-PET scans to postmortem beta-amyloid histopathology in 59 autopsy cases Alzheimer's & Dementia. 8: P90-P91. DOI: 10.1016/J.Jalz.2012.05.222 |
0.626 |
|
| 2011 |
Virostko J, Henske J, Vinet L, Lamprianou S, Dai C, Radhika A, Baldwin RM, Ansari MS, Hefti F, Skovronsky D, Kung HF, Herrera PL, Peterson TE, Meda P, Powers AC. Multimodal image coregistration and inducible selective cell ablation to evaluate imaging ligands. Proceedings of the National Academy of Sciences of the United States of America. 108: 20719-24. PMID 22143775 DOI: 10.1073/Pnas.1109480108 |
0.683 |
|
| 2011 |
Sabbagh MN, Fleisher A, Chen K, Rogers J, Berk C, Reiman E, Pontecorvo M, Mintun M, Skovronsky D, Jacobson SA, Sue LI, Liebsack C, Charney AS, Cole L, Belden C, et al. Positron emission tomography and neuropathologic estimates of fibrillar amyloid-β in a patient with Down syndrome and Alzheimer disease. Archives of Neurology. 68: 1461-6. PMID 22084131 DOI: 10.1001/Archneurol.2011.535 |
0.709 |
|
| 2011 |
Zha Z, Choi SR, Ploessl K, Lieberman BP, Qu W, Hefti F, Mintun M, Skovronsky D, Kung HF. Multidentate (18)F-polypegylated styrylpyridines as imaging agents for Aβ plaques in cerebral amyloid angiopathy (CAA). Journal of Medicinal Chemistry. 54: 8085-98. PMID 22011144 DOI: 10.1021/Jm2009106 |
0.718 |
|
| 2011 |
Tsao HH, Skovronsky DM, Lin KJ, Yen TC, Wey SP, Kung MP. Sigma receptor binding of tetrabenazine series tracers targeting VMAT2 in rat pancreas. Nuclear Medicine and Biology. 38: 1029-34. PMID 21982574 DOI: 10.1016/J.Nucmedbio.2011.03.006 |
0.643 |
|
| 2011 |
Lin KJ, Lin WY, Hsieh CJ, Weng YH, Wey SP, Lu CS, Skovronsky D, Yen TC, Chang CJ, Kung MP, Hsiao IT. Optimal scanning time window for 18F-FP-(+)-DTBZ (18F-AV-133) summed uptake measurements. Nuclear Medicine and Biology. 38: 1149-55. PMID 21831650 DOI: 10.1016/J.Nucmedbio.2011.05.010 |
0.62 |
|
| 2011 |
Villemagne VL, Okamura N, Pejoska S, Drago J, Mulligan RS, Chételat G, Ackermann U, O'Keefe G, Jones G, Gong S, Tochon-Danguy H, Kung HF, Masters CL, Skovronsky DM, Rowe CC. In vivo assessment of vesicular monoamine transporter type 2 in dementia with lewy bodies and Alzheimer disease. Archives of Neurology. 68: 905-12. PMID 21747030 DOI: 10.1001/Archneurol.2011.142 |
0.702 |
|
| 2011 |
Fleisher AS, Chen K, Liu X, Roontiva A, Thiyyagura P, Ayutyanont N, Joshi AD, Clark CM, Mintun MA, Pontecorvo MJ, Doraiswamy PM, Johnson KA, Skovronsky DM, Reiman EM. Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease. Archives of Neurology. 68: 1404-11. PMID 21747008 DOI: 10.1001/Archneurol.2011.150 |
0.725 |
|
| 2011 |
Lister-James J, Pontecorvo MJ, Clark C, Joshi AD, Mintun MA, Zhang W, Lim N, Zhuang Z, Golding G, Choi SR, Benedum TE, Kennedy P, Hefti F, Carpenter AP, Kung HF, Skovronsky DM, et al. Florbetapir f-18: a histopathologically validated Beta-amyloid positron emission tomography imaging agent. Seminars in Nuclear Medicine. 41: 300-4. PMID 21624563 DOI: 10.1053/J.Semnuclmed.2011.03.001 |
0.717 |
|
| 2011 |
Clark CM, Schneider JA, Bedell BJ, Beach TG, Bilker WB, Mintun MA, Pontecorvo MJ, Hefti F, Carpenter AP, Flitter ML, Krautkramer MJ, Kung HF, Coleman RE, Doraiswamy PM, Fleisher AS, ... Skovronsky DM, et al. Use of florbetapir-PET for imaging beta-amyloid pathology. Jama. 305: 275-83. PMID 21245183 DOI: 10.1001/Jama.2010.2008 |
0.736 |
|
| 2011 |
Skovronsky D. Amyloid imaging with 18F-AV-45 (florbetapir F 18) Neuroscience Research. 71: e39. DOI: 10.1016/j.neures.2011.07.173 |
0.66 |
|
| 2011 |
Pontecorvo MJ, Joshi A, Skovronsky D, Clark C, Mintun M. O4-07-03: Florbetapir PET correlates with cognitive decline, PIB PET and CSF markers in the ADNI database Alzheimer's & Dementia. 7: S697-S697. DOI: 10.1016/j.jalz.2011.05.2014 |
0.598 |
|
| 2010 |
Hefti FF, Kung HF, Kilbourn MR, Carpenter AP, Clark CM, Skovronsky DM. (18)F-AV-133: A Selective VMAT2-binding Radiopharmaceutical for PET Imaging of Dopaminergic Neurons. Pet Clinics. 5: 75-82. PMID 27157484 DOI: 10.1016/J.Cpet.2010.02.001 |
0.68 |
|
| 2010 |
Lin KJ, Weng YH, Wey SP, Hsiao IT, Lu CS, Skovronsky D, Chang HP, Kung MP, Yen TC. Whole-body biodistribution and radiation dosimetry of 18F-FP-(+)-DTBZ (18F-AV-133): a novel vesicular monoamine transporter 2 imaging agent. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 1480-5. PMID 20720042 DOI: 10.2967/Jnumed.110.078196 |
0.673 |
|
| 2010 |
Yao CH, Lin KJ, Weng CC, Hsiao IT, Ting YS, Yen TC, Jan TR, Skovronsky D, Kung MP, Wey SP. GMP-compliant automated synthesis of [(18)F]AV-45 (Florbetapir F 18) for imaging beta-amyloid plaques in human brain. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 68: 2293-7. PMID 20638295 DOI: 10.1016/J.Apradiso.2010.07.001 |
0.703 |
|
| 2010 |
Wong DF, Rosenberg PB, Zhou Y, Kumar A, Raymont V, Ravert HT, Dannals RF, Nandi A, Brasić JR, Ye W, Hilton J, Lyketsos C, Kung HF, Joshi AD, Skovronsky DM, et al. In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18). Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 913-20. PMID 20501908 DOI: 10.2967/Jnumed.109.069088 |
0.733 |
|
| 2010 |
Jagust WJ, Bandy D, Chen K, Foster NL, Landau SM, Mathis CA, Price JC, Reiman EM, Skovronsky D, Koeppe RA. The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 6: 221-9. PMID 20451870 DOI: 10.1016/J.Jalz.2010.03.003 |
0.712 |
|
| 2010 |
Lin KJ, Hsu WC, Hsiao IT, Wey SP, Jin LW, Skovronsky D, Wai YY, Chang HP, Lo CW, Yao CH, Yen TC, Kung MP. Whole-body biodistribution and brain PET imaging with [18F]AV-45, a novel amyloid imaging agent--a pilot study. Nuclear Medicine and Biology. 37: 497-508. PMID 20447562 DOI: 10.1016/j.nucmedbio.2010.02.003 |
0.711 |
|
| 2010 |
Tsao HH, Lin KJ, Juang JH, Skovronsky DM, Yen TC, Wey SP, Kung MP. Binding characteristics of 9-fluoropropyl-(+)-dihydrotetrabenzazine (AV-133) to the vesicular monoamine transporter type 2 in rats. Nuclear Medicine and Biology. 37: 413-9. PMID 20447551 DOI: 10.1016/J.Nucmedbio.2010.01.002 |
0.644 |
|
| 2010 |
Okamura N, Villemagne VL, Drago J, Pejoska S, Dhamija RK, Mulligan RS, Ellis JR, Ackermann U, O'Keefe G, Jones G, Kung HF, Pontecorvo MJ, Skovronsky D, Rowe CC. In vivo measurement of vesicular monoamine transporter type 2 density in Parkinson disease with (18)F-AV-133. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 223-8. PMID 20080893 DOI: 10.2967/Jnumed.109.070094 |
0.657 |
|
| 2010 |
Kung HF, Choi SR, Qu W, Zhang W, Skovronsky D. 18F stilbenes and styrylpyridines for PET imaging of Aβ plaques in Alzheimer's disease: A miniperspective Journal of Medicinal Chemistry. 53: 933-941. PMID 19845387 DOI: 10.1021/Jm901039Z |
0.719 |
|
| 2010 |
Sperling RA, Doraiswamy PM, Johnson K, Reiman EM, Sabbagh MN, Sadowsky CH, Carpenter A, Clark CM, Flitter M, Pontecorvo MJ, Skovronsky DM. O1-02-04: Florbetapir F 18 (18
F-AV-45) PET amyloid imaging predicts progression of cognitive impairment: A longitudinal clinical follow up study Alzheimer's & Dementia. 6: S71-S71. DOI: 10.1016/J.Jalz.2010.05.212 |
0.661 |
|
| 2010 |
Hefti FF, Kung HF, Kilbourn MR, Carpenter AP, Clark CM, Skovronsky DM. 18F-AV-133: A selective VMAT2-binding radiopharmaceutical for PET imaging of dopaminergic neurons Pet Clinics. 5: 75-82. DOI: 10.1016/j.cpet.2010.02.001 |
0.638 |
|
| 2009 |
Choi SR, Golding G, Zhuang Z, Zhang W, Lim N, Hefti F, Benedum TE, Kilbourn MR, Skovronsky D, Kung HF. Preclinical properties of 18F-AV-45: a PET agent for Abeta plaques in the brain. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 50: 1887-94. PMID 19837759 DOI: 10.2967/Jnumed.109.065284 |
0.741 |
|
| 2009 |
Carpenter AP, Pontecorvo MJ, Hefti FF, Skovronsky DM. The use of the exploratory IND in the evaluation and development of 18F-PET radiopharmaceuticals for amyloid imaging in the brain: a review of one company's experience. The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (Aimn) [and] the International Association of Radiopharmacology (Iar), [and] Section of the Society of Radiopharmaceutical Chemistry and Biology. 53: 387-93. PMID 19834448 |
0.708 |
|
| 2009 |
Wey SP, Weng CC, Lin KJ, Yao CH, Yen TC, Kung HF, Skovronsky D, Kung MP. Validation of an (18)F-labeled biphenylalkyne as a positron emission tomography imaging agent for beta-amyloid plaques. Nuclear Medicine and Biology. 36: 411-7. PMID 19423009 DOI: 10.1016/J.Nucmedbio.2009.01.013 |
0.726 |
|
| 2009 |
Doraiswamy PM, Farmer M, Holub R, Johnson K, Reiman EM, Sadowsky C, Safirstein B, Spicer K, Carpenter A, Clark CM, Joshi A, Veeraraj C, Pontecorvo MJ, Skovronsky D. O1-01-03: Relationship between regional amyloid levels and cognitive performance in healthy controls, MCI subjects, and patients with alzheimer's: Phase II results from a florpiramine F18 PET imaging study Alzheimer's & Dementia. 5: P77-P77. DOI: 10.1016/J.Jalz.2009.05.189 |
0.669 |
|
| 2009 |
Sperling R, Johnson K, Pontecorvo MJ, Safirstein B, Farmer M, Holub R, Korn R, Spicer K, Doraiswamy M, Reiman EM, Joshi A, Saha K, Flitter M, Clark CM, Skovronsky DM. P1-084: PET imaging of β-amyloid with florpiramine F18 (18F-AV-45): Preliminary results from a phase II study of cognitively normal elderly subjects, individuals with mild cognitive impairment, and patients with a clinical diagnosis of Alzheimer's disease Alzheimer's & Dementia. 5: P197-P197. DOI: 10.1016/J.Jalz.2009.04.088 |
0.67 |
|
| 2008 |
Kung HF, Lieberman BP, Zhuang ZP, Oya S, Kung MP, Choi SR, Poessl K, Blankemeyer E, Hou C, Skovronsky D, Kilbourn M. In vivo imaging of vesicular monoamine transporter 2 in pancreas using an (18)F epoxide derivative of tetrabenazine. Nuclear Medicine and Biology. 35: 825-37. PMID 19026944 DOI: 10.1016/J.Nucmedbio.2008.08.004 |
0.652 |
|
| 2008 |
Qu W, Choi SR, Hou C, Zhuang Z, Oya S, Zhang W, Kung MP, Manchandra R, Skovronsky DM, Kung HF. Synthesis and evaluation of indolinyl- and indolylphenylacetylenes as PET imaging agents for beta-amyloid plaques. Bioorganic & Medicinal Chemistry Letters. 18: 4823-7. PMID 18707879 DOI: 10.1016/J.Bmcl.2008.07.077 |
0.701 |
|
| 2008 |
Kung MP, Hou C, Lieberman BP, Oya S, Ponde DE, Blankemeyer E, Skovronsky D, Kilbourn MR, Kung HF. In vivo imaging of β-cell mass in rats using 18F-FP-(+)- DTBZ: A potential PET ligand for studying diabetes mellitus Journal of Nuclear Medicine. 49: 1171-1176. PMID 18552132 DOI: 10.2967/Jnumed.108.051680 |
0.673 |
|
| 2008 |
Skovronsky D. Use of eINDs for evaluation of multiple related PET amyloid plaque imaging agents Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 49: 47N-48N. PMID 18511825 |
0.673 |
|
| 2008 |
Rowe CC, Ackerman U, Browne W, Mulligan R, Pike KL, O'Keefe G, Tochon-Danguy H, Chan G, Berlangieri SU, Jones G, Dickinson-Rowe KL, Kung HP, Zhang W, Kung MP, Skovronsky D, et al. Imaging of amyloid beta in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism. The Lancet. Neurology. 7: 129-35. PMID 18191617 DOI: 10.1016/S1474-4422(08)70001-2 |
0.722 |
|
| 2008 |
Rosenberg PB, Zhou Y, Kumar A, Ravert H, Brasic J, Ye W, Alexander M, Dannals R, Galecki J, Lyketsos C, Skovronsky D, Pontecorvo M, Wong DF. P1-284: In vivo imaging of amyloid deposition in Alzheimer's disease using the novel radioligand [18
F] Av-45 Alzheimer's & Dementia. 4: T300-T301. DOI: 10.1016/J.Jalz.2008.05.874 |
0.731 |
|
| 2008 |
Pontecorvo M, Coleman RE, Doraiswamy M, Lowe V, Mintun M, Morris J, Petersen R, Rosenberg P, Ross J, Sadowsky C, Williamson J, Wong D, Carpenter A, Hefti F, Skovronsky D. IC-P3-205: Development of novel 18
F Aβ amyloid imaging agents Alzheimer's & Dementia. 4: T88-T88. DOI: 10.1016/J.Jalz.2008.05.149 |
0.666 |
|
| 2008 |
Joshi A, Skovronsky D, Pontecorvo M. P2-025: A semiautomated method for quantification of 18F-labelled amyloid plaque imaging agents based on volume of interest and voxel-based statistical analyses Alzheimer's & Dementia. 4: T374-T375. DOI: 10.1016/J.Jalz.2008.05.1105 |
0.696 |
|
| 2006 |
Skovronsky DM, Lee VM, Trojanowski JQ. Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications. Annual Review of Pathology. 1: 151-70. PMID 18039111 DOI: 10.1146/Annurev.Pathol.1.110304.100113 |
0.732 |
|
| 2006 |
Newberg AB, Wintering NA, Plössl K, Hochold J, Stabin MG, Watson M, Skovronsky D, Clark CM, Kung MP, Kung HF. Safety, biodistribution, and dosimetry of 123I-IMPY: A novel amyloid plaque-imaging agent for the diagnosis of Alzheimer's disease Journal of Nuclear Medicine. 47: 748-754. PMID 16644743 |
0.662 |
|
| 2006 |
Clark CM, Newberg AB, Watson M, Wintering NA, Skovronsky DM, Kung HF. P2-343: Imaging amyloid with I123 IMPY SPECT Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.1183 |
0.678 |
|
| 2005 |
Kung M, Hou C, Zhuang Z, Skovronsky D, Kung HF. Erratum to “Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease” [Brain Research 1025 (2004) 98–105] Brain Research. 1031: 302. DOI: 10.1016/J.Brainres.2004.10.002 |
0.689 |
|
| 2004 |
Kung MP, Hou C, Zhuang ZP, Skovronsky D, Kung HF. Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease Brain Research. 1025: 98-105. PMID 15464749 DOI: 10.1016/J.Brainres.2004.08.004 |
0.72 |
|
| 2004 |
Skovronsky DM, Oberholtzer JC. Pathologic classification of peripheral nerve tumors. Neurosurgery Clinics of North America. 15: 157-66. PMID 15177315 DOI: 10.1016/J.Nec.2004.02.005 |
0.744 |
|
| 2004 |
Skovronsky D, Judkins AR, Kung M, Forman M, Martinez D, Hou C, Zhuang Z, Kung HF. P3-079 Characterization of neurodegenerative disease radioligands by tissue microarray analysis Neurobiology of Aging. 25: S375-S376. DOI: 10.1016/S0197-4580(04)81231-4 |
0.76 |
|
| 2004 |
Hou C, Kung M, Xiu Y, Skovronsky DM, Mach R, Kung HF. P2-188 Labeling amyloid plaque-like structures by radioiodinated ligands in rhesus monkey brain Neurobiology of Aging. 25: S281. DOI: 10.1016/S0197-4580(04)80934-5 |
0.662 |
|
| 2004 |
Kung M, Hou C, Zhuang Z, Skovronsky DM, Kung HF. O3-03-02 Binding of two potential imaging agents targeting amyloid plaques in Alzheimer's disease brains Neurobiology of Aging. 25: S57. DOI: 10.1016/S0197-4580(04)80192-1 |
0.701 |
|
| 2003 |
Kung HF, Kung MP, Zhuang ZP, Hou C, Lee CW, Plössl K, Zhuang B, Skovronsky DM, Lee VM, Trojanowski JQ. Iodinated tracers for imaging amyloid plaques in the brain. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 5: 418-26. PMID 14667496 DOI: 10.1016/J.Mibio.2003.09.003 |
0.802 |
|
| 2003 |
Kung MP, Skovronsky DM, Hou C, Zhuang ZP, Gur TL, Zhang B, Trojanowski JQ, Lee VM, Kung HF. Detection of amyloid plaques by radioligands for Abeta40 and Abeta42: potential imaging agents in Alzheimer's patients. Journal of Molecular Neuroscience : Mn. 20: 15-24. PMID 12663930 DOI: 10.1385/Jmn:20:1:15 |
0.785 |
|
| 2003 |
Lee EB, Skovronsky DM, Abtahian F, Doms RW, Lee VM. Secretion and intracellular generation of truncated Abeta in beta-site amyloid-beta precursor protein-cleaving enzyme expressing human neurons. The Journal of Biological Chemistry. 278: 4458-66. PMID 12480937 DOI: 10.1074/Jbc.M210105200 |
0.752 |
|
| 2002 |
Kung MP, Hou C, Zhuang ZP, Zhang B, Skovronsky D, Trojanowski JQ, Lee VMY, Kung HF. IMPY: An improved thioflavin-T derivative for in vivo labeling of β-amyloid plaques Brain Research. 956: 202-210. PMID 12445687 DOI: 10.1016/S0006-8993(02)03436-4 |
0.767 |
|
| 2002 |
Saqi A, McGrath CM, Skovronsky D, Yu GH. Cytomorphologic features of fine-needle aspiration of metastatic and recurrent melanoma Diagnostic Cytopathology. 27: 286-290. PMID 12411994 DOI: 10.1002/dc.10194 |
0.537 |
|
| 2002 |
Kung MP, Hou C, Zhuang ZP, Skovronsky DM, Zhang B, Gur TL, Trojanowski JQ, Lee VM, Kung HF. Radioiodinated styrylbenzene derivatives as potential SPECT imaging agents for amyloid plaque detection in Alzheimer's disease. Journal of Molecular Neuroscience : Mn. 19: 7-10. PMID 12212796 DOI: 10.1007/S12031-002-0003-9 |
0.778 |
|
| 2001 |
Zhuang ZP, Kung MP, Hou C, Plössl K, Skovronsky D, Gur TL, Trojanowski JQ, Lee VM, Kung HF. IBOX(2-(4'-dimethylaminophenyl)-6-iodobenzoxazole): a ligand for imaging amyloid plaques in the brain. Nuclear Medicine and Biology. 28: 887-94. PMID 11711307 DOI: 10.1016/S0969-8051(01)00264-5 |
0.753 |
|
| 2001 |
Schmidt ML, Schuck T, Sheridan S, Kung MP, Kung H, Zhuang ZP, Bergeron C, Lamarche JS, Skovronsky D, Giasson BI, Lee VM, Trojanowski JQ. The fluorescent Congo red derivative, (trans, trans)-1-bromo-2,5-bis-(3-hydroxycarbonyl-4-hydroxy)styrylbenzene (BSB), labels diverse beta-pleated sheet structures in postmortem human neurodegenerative disease brains. The American Journal of Pathology. 159: 937-43. PMID 11549586 DOI: 10.1016/S0002-9440(10)61769-5 |
0.791 |
|
| 2001 |
Skovronsky DM, Fath S, Lee VM, Milla ME. Neuronal localization of the TNFalpha converting enzyme (TACE) in brain tissue and its correlation to amyloid plaques. Journal of Neurobiology. 49: 40-6. PMID 11536196 DOI: 10.1002/Neu.1064 |
0.715 |
|
| 2001 |
Lee CW, Zhuang ZP, Kung MP, Plössl K, Skovronsky D, Gur T, Hou C, Trojanowski JQ, Lee VMY, Kung HF. Isomerization of (Z,Z) to (E,E)1-bromo-2,5-bis-(3- hydroxycarbonyl-4-hydroxy)-styrylbenzene in strong base: Probes for amyloid plaques in the brain Journal of Medicinal Chemistry. 44: 2270-2275. PMID 11428920 DOI: 10.1021/Jm010161T |
0.712 |
|
| 2001 |
Zhuang ZP, Kung MP, Hou C, Skovronsky DM, Gur TL, Plössl K, Trojanowski JQ, Lee VM, Kung HF. Radioiodinated styrylbenzenes and thioflavins as probes for amyloid aggregates. Journal of Medicinal Chemistry. 44: 1905-14. PMID 11384236 DOI: 10.1021/Jm010045Q |
0.772 |
|
| 2001 |
Skovronsky DM, Lee VM, Praticò D. Amyloid precursor protein and amyloid beta peptide in human platelets. Role of cyclooxygenase and protein kinase C. The Journal of Biological Chemistry. 276: 17036-43. PMID 11278299 DOI: 10.1074/Jbc.M006285200 |
0.713 |
|
| 2000 |
Skovronsky DM, Wang J, Lee VM, Doms RW. Quantifying Aβ(1-40) and Aβ (1-42) Using Sandwich-ELISA. Methods in Molecular Medicine. 32: 79-89. PMID 21318512 DOI: 10.1385/1-59259-195-7:79 |
0.719 |
|
| 2000 |
Skovronsky DM, Zhang B, Kung MP, Kung HF, Trojanowski JQ, Lee VM. In vivo detection of amyloid plaques in a mouse model of Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America. 97: 7609-14. PMID 10861023 DOI: 10.1073/Pnas.97.13.7609 |
0.771 |
|
| 2000 |
Skovronsky DM, Lee VM. Beta-secretase revealed: starting gate for race to novel therapies for Alzheimer's disease. Trends in Pharmacological Sciences. 21: 161-3. PMID 10785643 DOI: 10.1016/S0165-6147(00)01467-X |
0.708 |
|
| 2000 |
Skovronsky DM, Pijak DS, Doms RW, Lee VM. A distinct ER/IC gamma-secretase competes with the proteasome for cleavage of APP. Biochemistry. 39: 810-7. PMID 10651647 DOI: 10.1021/Bi991728Z |
0.715 |
|
| 2000 |
Skovronsky DM, Moore DB, Milla ME, Doms RW, Lee VM. Protein kinase C-dependent alpha-secretase competes with beta-secretase for cleavage of amyloid-beta precursor protein in the trans-golgi network. The Journal of Biological Chemistry. 275: 2568-75. PMID 10644715 DOI: 10.1074/Jbc.275.4.2568 |
0.682 |
|
| 2000 |
Skovronsky DM, Zhang B, Kung M, Kung HF, Trojanowski JQ, Lee VM. In vivo detection of amyloid plaques in a mouse model of Alzheimer's disease Neurobiology of Aging. 21: 178. DOI: 10.1016/S0197-4580(00)82140-5 |
0.326 |
|
| 1998 |
Skovronsky DM, Doms RW, Lee VM. Detection of a novel intraneuronal pool of insoluble amyloid beta protein that accumulates with time in culture. The Journal of Cell Biology. 141: 1031-9. PMID 9585420 DOI: 10.1083/Jcb.141.4.1031 |
0.725 |
|
| 1994 |
Morgan NS, Skovronsky DM, Artavanis-Tsakonas S, Mooseker MS. The molecular cloning and characterization of Drosophila melanogaster myosin-IA and myosin-IB. Journal of Molecular Biology. 239: 347-56. PMID 8201616 DOI: 10.1006/jmbi.1994.1376 |
0.533 |
|
| Show low-probability matches. |